- CAS
- 159351-68-5
- Formula
- C59H97NO14Si
- MW
- 1072.5 g/mol
Everolimus EP Impurity B
Synonyms: Everolimus - Impurity B · Everolimus-19-ene open ring · (19E/Z)-seco-[4-O-(2-Hydroxyethyl)]Rapamycin
Everolimus EP Impurity B (CAS 1062122-63-7) – Everolimus impurity standard. C53H83NO14, MW 958.2. Supplied by Vaqora Chemicals with COA, exported worldwide.
About Everolimus EP Impurity B
Everolimus EP Impurity B is a pharmacopeial impurity of Everolimus carrying the CAS registry number 1062122-63-7. The compound has the formula C53H83NO14, corresponding to a molecular weight of 958.2 g/mol. Common synonyms include Everolimus - Impurity B and Everolimus-19-ene open ring.
The product is provided as a solid. Reference materials should be stored sealed and away from light and moisture, as specified on the accompanying COA. Good laboratory practice and suitable PPE are recommended during handling.
This Everolimus impurity supports analytical method development and validation (AMV), batch release testing and the impurity sections of ANDA and DMF filings. It is used across pharmaceutical manufacturing and academic and industrial research.
Available in 10 mg, 25 mg, 50 mg and 100 mg packs, Everolimus EP Impurity B is dispatched with a Certificate of Analysis (COA) to destinations worldwide.
Typical applications
- Pharmacopeial method verification
- Impurity profiling
- QC release testing
- ANDA / DMF filings
Industries
View every impurity, metabolite and intermediate we list for Everolimus.
Everolimus impuritiesGrade guides
Specifications & identifiers
| Product name | Everolimus EP Impurity B |
|---|---|
| Catalogue No. | VQ-030641 |
| CAS Number | 1062122-63-7 |
| IUPAC name | (2S)-1-[2-[(2R,3R,6S)-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaenyl]-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylic acid |
| Molecular formula | C53H83NO14 |
| Molecular weight | 958.2 g/mol |
| Exact mass | 957.5814 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | PRSJHEVLVQFMHJ-FRLQEACCSA-N |
| SMILES | C[C@@H]1CC[C@H](O[C@]1(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)OCCO)/C)O)OC)/C)OC |
| PubChem CID | 139025362 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | 7.4 |
| H-bond donors / acceptors | 4 / 14 |
| TPSA | 216 Ų |
Documents
Frequently asked questions
What is the CAS number of Everolimus EP Impurity B?
The CAS Registry Number of Everolimus EP Impurity B is 1062122-63-7. It is also known as Everolimus - Impurity B, Everolimus-19-ene open ring, (19E/Z)-seco-[4-O-(2-Hydroxyethyl)]Rapamycin.
What is the molecular formula and molecular weight of Everolimus EP Impurity B?
Everolimus EP Impurity B has the molecular formula C53H83NO14 and a molecular weight of 958.2 g/mol.
What is Everolimus EP Impurity B used for?
Everolimus EP Impurity B is supplied as a characterised reference material related to Everolimus. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
Which grade and pack sizes of Everolimus EP Impurity B can I order?
We supply Everolimus EP Impurity B in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.
Do you provide a COA and SDS with Everolimus EP Impurity B?
Yes. Every lot of Everolimus EP Impurity B is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Can Everolimus EP Impurity B be shipped internationally?
Yes. We export Everolimus EP Impurity B worldwide by air and sea freight or express courier, on EXW, FOB, CIF, CFR or DAP Incoterms, with full export documentation.
Enquire about Everolimus EP Impurity B
We reply within one business day with price, pack options, lead time and documentation.